STCOSD
WST icon

Sageworth Trust Company of South Dakota’s West Pharmaceutical WST Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21
Closed -$6K – 651
2022
Q2 		$6K Hold
21
– – 0.01% 221
2022
Q1 		$9K Sell
21
-98
-82% -$38.4K 0.02% 216
2021
Q4 		$56K Buy
+119
New +$51.2K 0.09% 94

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sageworth Trust Company of South Dakota's WST Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 21 shares — an estimated $6K sold.

Sageworth Trust Company of South Dakota first reported a position in WST in Q4 2021 and held it in 3 quarters. The position peaked at $56K in Q4 2021. 639 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 21 West Pharmaceutical shares in Q3 2022, an estimated $6K.
  • Sageworth Trust Company of South Dakota first reported a position in West Pharmaceutical in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's West Pharmaceutical position peaked at $56K in Q4 2021.
  • 639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.